Login

Healthcare

00:00:00
Scancell Holdings' present progression and pipeline plan now firm is fully funded for all programmes - Professor Lindy Durrant (Chief Executive Officer, Chief Scientific Officer), Scancell Holdings
00:00:00
Scancell Holdings PLC (AIM:SCLP) (OTC:SCNLF) - Lindy Durrant CEO - Professor Lindy Durrant (Chief Executive Officer, Chief Scientific Officer), Scancell Holdings
00:00:00
Scancell CEO hails "exciting" high response rate to melanoma treatment - Professor Lindy Durrant (Chief Executive Officer, Chief Scientific Officer), Scancell Holdings
00:00:00
Sensorion seeks partner for inner ear disorder drug - Nawal Ouzren, CEO, Sensorion
00:00:00
SenzaGen presentation - Peter Nählstedt President and CEO, SenzaGen
00:00:00
SenzaGen CEO Peter Nählstedt present the company - Peter Nählstedt President and CEO, SenzaGen
00:00:00
SenzaGen CEO Peter Nählstedt presents the company at Vator Securities Healthcare Innovation Summit - Peter Nählstedt President and CEO, SenzaGen
00:00:00
SenzaGen presentation - Peter Nählstedt President and CEO, SenzaGen
00:00:00
CEO Peter Nählstedt presents SenzaGen - Peter Nählstedt President and CEO, SenzaGen
00:00:00
CEO Pia Renaudin presents Senzime - Pia Renaudin, CEO, Senzime AB (publ)
00:00:00
Interview with Dr. Philip Toleikis, President & CEO of Sernova Corp. - Dr. Philip Toleikis, President & CEO of Sernova Corp.
00:00:00
Shield Therapeutics "ended 2022 in a very very productive state" - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics 'delivered an excellent first half' with Accrufer powering ahead in the US - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics talks extension of cash runway following US$10 million financing - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics' present drive for US launch success of iron deficiency product Accrufer - Greg Madison Chief Executive Officer, Shield Therapeutics P

© 2017 - Townhall + Tv